دورية أكاديمية
Phospholipase A 2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1.
العنوان: | Phospholipase A |
---|---|
المؤلفون: | Vecchi L; Laboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, Brazil., Araújo TG; Laboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, Brazil.; Laboratory of Genetics and Biotechnology, Federal University of Uberlandia, Patos de Minas 387400-128, MG, Brazil., Azevedo FVPV; Laboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, Brazil., Mota STS; Laboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, Brazil., Ávila VMR; Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, Brazil., Ribeiro MA; Laboratory of Genetics and Biotechnology, Federal University of Uberlandia, Patos de Minas 387400-128, MG, Brazil., Goulart LR; Laboratory of Nanobiotechnology, Federal University of Uberlandia, Uberlandia 38400-902, MG, Brazil. |
المصدر: | Cells [Cells] 2021 Jun 11; Vol. 10 (6). Date of Electronic Publication: 2021 Jun 11. |
نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't; Review |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI |
مواضيع طبية MeSH: | Annexin A1/*metabolism , Carcinogenesis/*pathology , Neoplasms/*pathology , Phospholipases A2/*metabolism, Animals ; Carcinogenesis/metabolism ; Humans ; Neoplasms/metabolism |
مستخلص: | Phospholipids are suggested to drive tumorigenesis through their essential role in inflammation. Phospholipase A |
References: | Pharmacol Ther. 2017 May;173:118-134. (PMID: 28188812) FASEB J. 2018 Mar;32(3):1468-1478. (PMID: 29127186) Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:39-47. (PMID: 15962097) Int J Mol Sci. 2018 Mar 31;19(4):. (PMID: 29614751) Mol Cell Pharmacol. 2009;1(1):29-43. (PMID: 20333321) Methods Mol Biol. 2018;1835:69-105. (PMID: 30109646) Cancer Cell. 2015 Apr 13;27(4):450-61. (PMID: 25858804) J Infect Dis. 2016 Jul 15;214(2):237-47. (PMID: 27034344) J Clin Invest. 2015 Sep;125(9):3356-64. (PMID: 26168215) Int J Biochem Cell Biol. 2020 Oct;127:105838. (PMID: 32858191) Oncotarget. 2017 Dec 23;9(2):2697-2704. (PMID: 29416802) Front Immunol. 2019 Apr 30;10:938. (PMID: 31114582) Cancer Res. 2007 May 1;67(9):4507-13. (PMID: 17483367) J Immunol. 2010 Sep 1;185(5):3057-63. (PMID: 20679535) Anticancer Res. 2013 Apr;33(4):1337-42. (PMID: 23564770) Immunity. 2008 Sep 19;29(3):372-83. (PMID: 18799145) Science. 2010 Jan 29;327(5965):580-3. (PMID: 20110505) J Biol Chem. 2007 Dec 7;282(49):35679-86. (PMID: 17932043) Cancer Res. 2006 Jan 15;66(2):1123-31. (PMID: 16424049) Chem Rev. 2011 Oct 12;111(10):5821-65. (PMID: 21942677) Immunol Rev. 2009 May;229(1):126-44. (PMID: 19426219) Cell Metab. 2016 May 10;23(5):930-44. (PMID: 27133131) Cell. 2017 Feb 9;168(4):670-691. (PMID: 28187288) Sci Signal. 2017 Aug 29;10(494):. (PMID: 28851824) Science. 2011 Jan 7;331(6013):44-9. (PMID: 21212348) Nat Rev Rheumatol. 2013 Oct;9(10):595-603. (PMID: 23958797) Biomolecules. 2020 Oct 19;10(10):. (PMID: 33086624) Cell. 2011 Mar 4;144(5):646-74. (PMID: 21376230) Clin Immunol. 2018 Nov;196:64-71. (PMID: 29501540) Mol Cancer. 2019 Mar 30;18(1):50. (PMID: 30925930) Cell Death Discov. 2019 Sep 23;5:135. (PMID: 31552142) Oncogene. 2011 Sep 8;30(36):3887-99. (PMID: 21499310) Curr Drug Targets Immune Endocr Metabol Disord. 2003 Mar;3(1):23-32. (PMID: 12570723) J Immunol. 2006 Jan 1;176(1):284-90. (PMID: 16365420) Cancer Res. 2009 Mar 1;69(5):1733-8. (PMID: 19208832) Ann Thorac Surg. 2011 May;91(5):1539-45. (PMID: 21396625) Cancer Invest. 2009 Dec;27(10):1023-37. (PMID: 19909018) Nat Rev Cancer. 2017 Aug;17(8):457-474. (PMID: 28706266) Biochim Biophys Acta. 2006 Nov;1761(11):1246-59. (PMID: 16973413) Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6340-5. (PMID: 20308542) J Thorac Oncol. 2012 Jul;7(7):1091-100. (PMID: 22534817) Am J Pathol. 2002 Sep;161(3):947-56. (PMID: 12213723) Biochem J. 2005 Apr 15;387(Pt 2):309-14. (PMID: 15537390) Reproduction. 2013 Nov 16;147(1):R1-14. (PMID: 24149515) Cancers (Basel). 2011 Aug 09;3(3):3189-205. (PMID: 24212952) Blood. 2009 Jul 9;114(2):357-9. (PMID: 19289853) FASEB J. 2010 Oct;24(10):4103-16. (PMID: 20530749) Cytokine Growth Factor Rev. 2010 Feb;21(1):61-5. (PMID: 20022797) Oncogenesis. 2017 Jul 3;6(7):e352. (PMID: 28671675) Science. 2013 Mar 29;339(6127):1546-58. (PMID: 23539594) Front Immunol. 2016 Feb 10;7:32. (PMID: 26904023) Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1368-1382. (PMID: 29932988) CA Cancer J Clin. 2020 Jan;70(1):7-30. (PMID: 31912902) Breast Cancer Res. 2008;10 Suppl 1:S2. (PMID: 19091006) Nat Rev Immunol. 2009 Mar;9(3):162-74. (PMID: 19197294) Annu Rev Biochem. 2004;73:321-54. (PMID: 15189145) Trends Mol Med. 2019 Apr;25(4):315-327. (PMID: 30871809) Cell. 2019 Apr 4;177(2):428-445.e18. (PMID: 30951670) Signal Transduct Target Ther. 2021 Feb 26;6(1):94. (PMID: 33637672) Cancer Lett. 2020 Feb 1;470:126-133. (PMID: 31730903) Cancer Res. 2007 Aug 1;67(15):7458-66. (PMID: 17671216) J Immunother. 2012 Feb-Mar;35(2):179-88. (PMID: 22306906) Lipids. 2016 Oct;51(10):1153-1159. (PMID: 27540737) Annu Rev Biochem. 2000;69:145-82. (PMID: 10966456) Front Pharmacol. 2019 Dec 17;10:1479. (PMID: 31920664) Molecules. 2016 Jan 15;21(1):82. (PMID: 26784155) Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15505-10. (PMID: 18832156) J Am Coll Cardiol. 2010 Sep 28;56(14):1079-88. (PMID: 20863951) Blood. 2003 May 15;101(10):4140-7. (PMID: 12560218) FASEB J. 2012 Aug;26(8):3306-20. (PMID: 22767227) J Lipid Res. 2015 Jul;56(7):1245-7. (PMID: 26031662) Biochim Biophys Acta. 2000 Oct 31;1488(1-2):59-70. (PMID: 11080677) Br J Cancer. 2011 Jan 18;104(2):338-44. (PMID: 21119660) Cancer Lett. 2008 Aug 28;267(2):204-15. (PMID: 18448242) Acta Histochem. 2014 Sep;116(7):1178-84. (PMID: 25028131) Expert Opin Biol Ther. 2021 Feb;21(2):241-258. (PMID: 32813990) Biochim Biophys Acta. 2000 Oct 31;1488(1-2):1-19. (PMID: 11080672) Science. 2009 May 22;324(5930):1029-33. (PMID: 19460998) Int J Inflam. 2014;2014:651503. (PMID: 25152827) Int J Biol Macromol. 2016 Jan;82:671-7. (PMID: 26519876) Biochimie. 2014 Dec;107 Pt A:114-23. (PMID: 25286228) Biochim Biophys Acta. 2006 Nov;1763(11):1320-4. (PMID: 17023068) Science. 2020 Feb 7;367(6478):. (PMID: 32029601) J Lipid Res. 2010 Aug;51(8):2105-20. (PMID: 20424270) Nat Rev Immunol. 2004 Dec;4(12):941-52. (PMID: 15573129) Blood. 2009 Aug 6;114(6):1141-9. (PMID: 19470694) Hepatology. 2014 Aug;60(2):531-44. (PMID: 24668763) Prog Lipid Res. 2020 Nov;80:101055. (PMID: 32791170) Immunology. 2013 Feb;138(2):105-15. (PMID: 23216602) Front Immunol. 2019 Jun 05;10:1234. (PMID: 31231378) J Cardiovasc Pharmacol. 2009 Jan;53(1):60-5. (PMID: 19129734) Am J Pathol. 2002 Feb;160(2):667-71. (PMID: 11839587) J Biol Chem. 2002 Oct 18;277(42):39436-42. (PMID: 12176993) Trends Immunol. 2012 Mar;33(3):119-26. (PMID: 22277903) Int J Mol Sci. 2019 Mar 16;20(6):. (PMID: 30884823) Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228. (PMID: 29339798) Am J Cancer Res. 2017 May 01;7(5):1016-1036. (PMID: 28560055) Sci Rep. 2017 Aug 1;7(1):7077. (PMID: 28765552) Biochem Soc Trans. 2017 Feb 8;45(1):229-236. (PMID: 28202677) Cancer Res. 2004 Apr 15;64(8):2865-73. (PMID: 15087405) Cancer Res. 2004 Oct 1;64(19):6934-40. (PMID: 15466184) Cells. 2019 Jul 19;8(7):. (PMID: 31331117) J Agric Food Chem. 2019 Apr 17;67(15):4259-4272. (PMID: 30913881) Front Pharmacol. 2020 Nov 18;11:595498. (PMID: 33364964) Carcinogenesis. 2010 Nov;31(11):1948-55. (PMID: 20837598) Front Oncol. 2018 Oct 31;8:492. (PMID: 30430081) J Immunother Cancer. 2020 Apr;8(1):. (PMID: 32300050) J Exp Clin Cancer Res. 2020 May 18;39(1):89. (PMID: 32423420) Int J Mol Sci. 2018 May 12;19(5):. (PMID: 29757220) Apoptosis. 2020 Dec;25(11-12):817-834. (PMID: 32940876) J Inflamm (Lond). 2020 Aug 5;17:23. (PMID: 32774171) Sci Adv. 2020 Sep 16;6(38):. (PMID: 32938681) Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):941-956. (PMID: 30905350) Cell. 2013 Apr 25;153(3):666-77. (PMID: 23622249) Sci Rep. 2016 Jul 18;6:27028. (PMID: 27426034) Front Immunol. 2016 Dec 19;7:604. (PMID: 28066415) J Clin Oncol. 2005 Feb 10;23(5):953-64. (PMID: 15598976) Science. 1976 Oct 1;194(4260):23-8. (PMID: 959840) Int J Mol Sci. 2018 Dec 04;19(12):. (PMID: 30518142) Curr Oncol. 2009 May;16(3):46-9. (PMID: 19526085) Br J Cancer. 2013 Feb 19;108(3):587-96. (PMID: 23322202) J Lipid Res. 2015 Aug;56(8):1386-402. (PMID: 25838312) Biochim Biophys Acta. 2007 Apr;1768(4):923-40. (PMID: 17078925) Curr Biol. 2020 Aug 17;30(16):R921-R925. (PMID: 32810447) Arch Biochem Biophys. 2006 Mar 15;447(2):136-46. (PMID: 16527246) Cardiovasc Drugs Ther. 2009 Feb;23(1):49-59. (PMID: 18931897) Clin Cancer Res. 2008 Dec 15;14(24):8070-9. (PMID: 19088022) J Biol Chem. 2016 Jul 22;291(30):15588-601. (PMID: 27226632) J Immunol. 2004 Jul 15;173(2):945-54. (PMID: 15240681) Dev Cell. 2016 Jun 6;37(5):473-83. (PMID: 27270042) J Immunol. 2009 Nov 15;183(10):6320-9. (PMID: 19880450) Nat Rev Immunol. 2010 Apr;10(4):248-56. (PMID: 20336152) Trends Pharmacol Sci. 2003 May;24(5):245-52. (PMID: 12767724) Cancer Lett. 2021 Jan 28;497:165-177. (PMID: 33080311) Int Immunopharmacol. 2020 Sep;86:106700. (PMID: 32590316) Trends Immunol. 2016 Mar;37(3):208-220. (PMID: 26858199) J Clin Invest. 2015 Mar 2;125(3):1215-27. (PMID: 25664854) Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1117-1122. (PMID: 28096371) Trends Immunol. 2002 Nov;23(11):541-8. (PMID: 12401407) Haematologica. 2011 Sep;96(9):1302-9. (PMID: 21606166) Biomed Res Int. 2015;2015:314620. (PMID: 26583099) Biol Pharm Bull. 2006 Dec;29(12):2359-61. (PMID: 17142963) J Transl Med. 2020 Jun 22;18(1):249. (PMID: 32571337) Sci Rep. 2017 Dec 20;7(1):17925. (PMID: 29263330) Prostate. 2012 Jul 1;72(10):1140-9. (PMID: 22127954) J Thorac Cardiovasc Surg. 2012 Feb;143(2):405-11. (PMID: 22248682) Int J Cancer. 2010 Aug 15;127(4):759-67. (PMID: 20518016) Nat Immunol. 2018 Feb;19(2):108-119. (PMID: 29348500) J Immunol. 2005 Aug 1;175(3):1483-90. (PMID: 16034085) Nat Med. 2012 Jun;18(6):883-91. (PMID: 22635005) Annu Rev Immunol. 2007;25:171-92. (PMID: 17129182) Nat Rev Cancer. 2010 Mar;10(3):181-93. (PMID: 20168319) Cancer Metastasis Rev. 2006 Sep;25(3):315-22. (PMID: 16967326) Steroids. 2016 Jul;111:84-88. (PMID: 26930575) Biochimie. 2010 Jun;92(6):601-10. (PMID: 20362028) Molecules. 2018 Mar 18;23(3):. (PMID: 29562646) Biochim Biophys Acta. 2014 Mar;1841(3):416-21. (PMID: 24269828) Nature. 2014 Apr 3;508(7494):113-7. (PMID: 24695311) JAMA. 2014 Jan 15;311(3):252-62. (PMID: 24247616) Mod Pathol. 2003 Feb;16(2):130-6. (PMID: 12591965) Int J Mol Sci. 2013 Apr 02;14(4):7193-230. (PMID: 23549262) J Cell Physiol. 2010 Sep;224(3):757-65. (PMID: 20578244) Annu Rev Immunol. 2013;31:163-94. (PMID: 23298212) Int J Mol Sci. 2019 Mar 06;20(5):. (PMID: 30845751) Clin Gastroenterol Hepatol. 2004 Oct;2(10):880-7. (PMID: 15476151) J Immunol. 2010 Mar 1;184(5):2611-2619. (PMID: 20107188) Cancer Lett. 2017 Feb 28;387:61-68. (PMID: 26845449) J Cell Biochem. 2006 Dec 1;99(5):1298-307. (PMID: 16795041) J Immunol. 2012 Jan 1;188(1):135-45. (PMID: 22116825) Blood Cells Mol Dis. 2005 Sep-Oct;35(2):169-73. (PMID: 16081306) Int J Biol Macromol. 2019 Aug 15;135:261-273. (PMID: 31128190) Cancer Immunol Immunother. 2005 Sep;54(9):898-906. (PMID: 15776284) FEBS Lett. 2014 Aug 19;588(16):2712-27. (PMID: 24560789) J Clin Invest. 2011 Oct;121(10):3804-9. (PMID: 21965337) J Lipid Res. 2018 Nov;59(11):2037-2046. (PMID: 29678959) Nature. 2000 Sep 14;407(6801):249-57. (PMID: 11001068) Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13138-43. (PMID: 16924108) Front Immunol. 2019 May 28;10:1159. (PMID: 31231367) J Pharmacol Exp Ther. 2000 Sep;294(3):793-9. (PMID: 10945826) BMC Cancer. 2016 Jul 18;16:490. (PMID: 27432059) Int J Cancer. 2009 Jun 1;124(11):2621-33. (PMID: 19235923) Int J Oncol. 2017 Jun;50(6):2113-2122. (PMID: 28440478) Hum Mol Genet. 2014 Jan 15;23(2):467-78. (PMID: 24067531) Atherosclerosis. 2010 Oct;212(2):357-66. (PMID: 20363471) Traffic. 2003 Apr;4(4):214-21. (PMID: 12694560) J Biosci. 2018 Jun;43(2):277-285. (PMID: 29872016) Semin Cancer Biol. 2020 May;62:192-200. (PMID: 31518697) Front Endocrinol (Lausanne). 2017 Aug 08;8:194. (PMID: 28848498) Carcinogenesis. 2010 Dec;31(12):2097-104. (PMID: 20732905) |
فهرسة مساهمة: | Keywords: Annexin A1; cancer aggressiveness; lipid metabolism; phospholipase A2; tumor microenvironment; tumorigenesis |
المشرفين على المادة: | 0 (Annexin A1) EC 3.1.1.4 (Phospholipases A2) |
تواريخ الأحداث: | Date Created: 20210702 Date Completed: 20211108 Latest Revision: 20211108 |
رمز التحديث: | 20240628 |
مُعرف محوري في PubMed: | PMC8231270 |
DOI: | 10.3390/cells10061472 |
PMID: | 34208346 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2073-4409 |
---|---|
DOI: | 10.3390/cells10061472 |